These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 3495601

  • 1. Effects of human alveolar macrophages on the induction of lymphokine (IL 2)-activated killer cells.
    Sone S, Utsugi T, Nii A, Ogura T.
    J Immunol; 1987 Jul 01; 139(1):29-34. PubMed ID: 3495601
    [Abstract] [Full Text] [Related]

  • 2. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
    Spits H, Yssel H, Paliard X, Kastelein R, Figdor C, de Vries JE.
    J Immunol; 1988 Jul 01; 141(1):29-36. PubMed ID: 2454260
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
    Loudon WG, Abraham SR, Owen-Schaub LB, Hemingway LL, Hemstreet GP, DeBault LE.
    Cancer Res; 1988 Apr 15; 48(8):2184-92. PubMed ID: 3258186
    [Abstract] [Full Text] [Related]

  • 5. Evidence that interleukin-4 suppression of lymphokine-activated killer cell induction is mediated through monocytes.
    Brooks B, Parry H, Lawry J, Rees R.
    Immunology; 1992 Feb 15; 75(2):343-8. PubMed ID: 1551696
    [Abstract] [Full Text] [Related]

  • 6. Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state.
    Nii A, Sone S, Utsugi T, Yanagawa H, Ogura T.
    Int J Cancer; 1988 Jan 15; 41(1):33-40. PubMed ID: 2826345
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.
    Gamero AM, Ussery D, Reintgen DS, Puleo CA, Djeu JY.
    Cancer Res; 1995 Nov 01; 55(21):4988-94. PubMed ID: 7585540
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of lymphokine-activated killer cell function by human alveolar macrophages.
    Roth MD, Golub SH.
    Cancer Res; 1989 Sep 01; 49(17):4690-5. PubMed ID: 2788029
    [Abstract] [Full Text] [Related]

  • 9. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
    Atzpodien J, Gulati SC.
    Stem Cells; 1993 Nov 01; 11(6):511-8. PubMed ID: 8111310
    [Abstract] [Full Text] [Related]

  • 10. Destruction of autologous human lymphocytes by interleukin 2-activated cytotoxic cells.
    Sondel PM, Hank JA, Kohler PC, Chen BP, Minkoff DZ, Molenda JA.
    J Immunol; 1986 Jul 15; 137(2):502-11. PubMed ID: 2424971
    [Abstract] [Full Text] [Related]

  • 11. Protection of cultured human monocytes from lymphokine-activated killer-mediated lysis by IFN-gamma.
    Blanchard DK, Djeu JY.
    J Immunol; 1988 Dec 01; 141(11):4067-73. PubMed ID: 2460557
    [Abstract] [Full Text] [Related]

  • 12. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec 01; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 13. Recombinant interleukin 4 (RIL4) inhibits interleukin 2-induced activation of peripheral blood lymphocytes.
    Han X, Itoh K, Balch CM, Pellis NR.
    Lymphokine Res; 1988 Dec 01; 7(3):227-35. PubMed ID: 3263554
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effects of alloimmune T cells on the generation of cytolytic responses of lymphokine-activated killer cells.
    Sugarbaker PH, Matthews W, Steller EP, Eggermont AM.
    J Biol Response Mod; 1987 Aug 01; 6(4):430-45. PubMed ID: 3498012
    [Abstract] [Full Text] [Related]

  • 15. Characterization and modulation of human lymphokine (interleukin 2) activated killer cell induction.
    Hoyer M, Meineke T, Lewis W, Zwilling B, Rinehart J.
    Cancer Res; 1986 Jun 01; 46(6):2834-8. PubMed ID: 2421884
    [Abstract] [Full Text] [Related]

  • 16. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD, Economou JS, Shau H, Golub SH.
    J Surg Res; 1993 Nov 01; 55(5):486-92. PubMed ID: 8231167
    [Abstract] [Full Text] [Related]

  • 17. Human pulmonary natural killer (NK) cells exhibit limited lymphokine-activated killer (LAK) activity.
    Yarbrough WC, Weissler JC.
    Am J Respir Cell Mol Biol; 1989 Oct 01; 1(4):305-11. PubMed ID: 2483121
    [Abstract] [Full Text] [Related]

  • 18. Lymphokine activated killer (LAK) cell-mediated endothelial injury: a mechanism for capillary leak syndrome in patients treated with LAK cells and interleukin-2.
    Kotasek D, Vercellotti GM, Ochoa AC, Bach FH, Jacob HS.
    Trans Assoc Am Physicians; 1987 Oct 01; 100():21-7. PubMed ID: 3502662
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K, Varalakshmi C, Khar A.
    Cytokines Cell Mol Ther; 1997 Mar 01; 3(1):51-8. PubMed ID: 9287244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.